Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3029% below fair value
$4.90+0.13 (+2.73%)
Close on Nov 13, 2026Market cap $553.99MP/E –Yield –
Evolent Health total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Evolent Health's total debt was $969.48M at Sep 30, 2026. For fiscal 2025 it was $970.54M, up 46.6% from the year before. The highest annual figure on record is $970.54M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $970.54M | +46.6% |
| FY2024 | Dec 31, 2024 | $661.99M | +10.9% |
| FY2023 | Dec 31, 2023 | $597.05M | +44.6% |
| FY2022 | Dec 31, 2022 | $412.99M | +91.5% |
| FY2021 | Dec 31, 2021 | $215.68M | -25.6% |
| FY2020 | Dec 31, 2020 | $289.90M | -1.3% |
| FY2019 | Dec 31, 2019 | $293.67M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $969.48M | -8.5% |
| Q2 FY2026 | Jun 30, 2026 | $966.47M | +17.8% |
| Q1 FY2026 | Mar 31, 2026 | $973.49M | +18.8% |
| Q4 FY2025 | Dec 31, 2025 | $970.54M | +46.6% |
| Q3 FY2025 | Sep 30, 2025 | $1.06B | +76.8% |
| Q2 FY2025 | Jun 30, 2025 | $820.57M | +37.0% |
| Q1 FY2025 | Mar 31, 2025 | $819.33M | +37.0% |
| Q4 FY2024 | Dec 31, 2024 | $661.99M | +10.9% |
| Q3 FY2024 | Sep 30, 2024 | $599.67M | -0.2% |
| Q2 FY2024 | Jun 30, 2024 | $598.78M | -5.4% |
| Q1 FY2024 | Mar 31, 2024 | $597.90M | -5.4% |
| Q4 FY2023 | Dec 31, 2023 | $597.05M | +44.6% |
| Q3 FY2023 | Sep 30, 2023 | $600.94M | +45.7% |
| Q2 FY2023 | Jun 30, 2023 | $633.01M | +123.6% |
| Q1 FY2023 | Mar 31, 2023 | $632.28M | +123.7% |
| Q4 FY2022 | Dec 31, 2022 | $412.99M | +91.5% |
| Q3 FY2022 | Sep 30, 2022 | $412.44M | +73.5% |
| Q2 FY2022 | Jun 30, 2022 | $283.14M | +21.4% |
| Q1 FY2022 | Mar 31, 2022 | $282.60M | +23.5% |
| Q4 FY2021 | Dec 31, 2021 | $215.68M | -25.6% |
| Q3 FY2021 | Sep 30, 2021 | $237.77M | -19.0% |
| Q2 FY2021 | Jun 30, 2021 | $233.21M | – |
| Q1 FY2021 | Mar 31, 2021 | $228.74M | – |
| Q4 FY2020 | Dec 31, 2020 | $289.90M | – |
| Q4 FY2019 | Dec 31, 2019 | $293.67M | – |
See a number that looks wrong?